Search Results
Oct 14, 2025, 05:31 ET Infosys Chosen by NHSBSA to Deliver a New Workforce Management Solution for the NHS in England and Wales
contract by the NHS Business Services Authority (NHSBSA) to deliver the Future NHS Workforce Solution. Infosys will develop a cutting-edge, data-driven workforce management solution that will replace the current Electronic Staff Record (ESR) system and continue to pay 1.9 million NHS employees in England
More news about: Infosys
Oct 14, 2025, 05:25 ET Infosys Chosen by NHSBSA to Deliver a New Workforce Management Solution for the NHS in England and Wales
contract by the NHS Business Services Authority (NHSBSA) to deliver the Future NHS Workforce Solution. Infosys will develop a cutting-edge, data-driven workforce management solution that will replace the current Electronic Staff Record (ESR) system and continue to pay 1.9 million NHS employees in England
More news about: Infosys
Oct 09, 2025, 12:05 ET XRlabs SIM Named to TIME Best Inventions 2025
is a surgical intelligence company pioneering the next generation of surgical visualization and intraoperative guidance. Founded by neurosurgeon and NHS Clinical Entrepreneur Dr. Ali Haddad, XRlabs is headquartered in London and is dedicated to building a world where surgical excellence is borderless.
More news about: XRlabs
Oct 09, 2025, 11:57 ET XRlabs SIM Named to TIME Best Inventions 2025
is a surgical intelligence company pioneering the next generation of surgical visualization and intraoperative guidance. Founded by neurosurgeon and NHS Clinical Entrepreneur Dr. Ali Haddad, XRlabs is headquartered in London and is dedicated to building a world where surgical excellence is borderless.
More news about: XRlabs
Oct 09, 2025, 06:00 ET Kneu Health Secures $5.6M to Scale Next-Generation Neurology Care
Built on one of the world's largest Parkinson's and dementia datasets and adopted across major U.S. health systems and NHS Trusts, Kneu is creating a population-scale foundation for managing neurodegenerative decline
More news about: Kneu Health
Oct 09, 2025, 04:00 ET Focus Group Names Intermedia as Strategic Partner to Deliver AI-Powered, Fully Integrated Communications Solutions Across the UK
mission to empower businesses. By bringing these capabilities into our solutions portfolio, we're giving companies - and, in the case of Think Healthcare, NHS practices and private providers—the tools to improve access, streamline operations, and deliver exceptional outcomes while operating more efficiently."
More news about: Intermedia Cloud Communications
Oct 07, 2025, 08:30 ET Fannie Mae Publishes September 2025 National Housing Survey Results
National Housing Survey® (NHS), which includes the Home Purchase Sentiment Index® (HPSI), a measure of consumer sentiment toward housing. Month over month, the HPSI remained
More news about: Fannie Mae
Oct 02, 2025, 09:00 ET Aid cannot wait - Hydrachem urges global action to break barriers to clean water
disinfection and sterilisation. Operating in over 60 countries, the company partners with NGOs, governments and leading healthcare institutions, including the NHS, to combat waterborne diseases, maintain hygienic environments and produce over 10 billion litres of safe drinking water each year.
More news about: Hydrachem
Oct 01, 2025, 13:38 ET Moveworks and Simpplr Partner to Give Enterprises Greater Flexibility in the Digital Workplace
intuitive, highly extensible, and built to integrate seamlessly with your existing technology. More than 1,000 leading organizations — including AAA, the NHS, Penske, and Moderna — trust Simpplr to foster a more aligned and productive workforce. Headquartered in Silicon Valley with global offices, Simpplr
More news about: Simpplr
Sep 30, 2025, 16:30 ET NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
YORK, Sept. 30, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on October
More news about: Neuberger Berman
Sep 30, 2025, 10:40 ET RTLS Market For Healthcare Is Projected To Reach US$10.66 Billion By 2031, at CAGR Of 18.6% Amid Growing Chronic Diseases Burden | The Insight Partners
change. Within the UK, in 2023-24, NHS England conducted a pilot study of an RTLS system as a Clinical Innovation Delivery Support Project across several treatment centers and operating theatres at Mid Cheshire Hospitals NHS Foundation Trust, which was able to track the location and
More news about: The Insight Partners
Sep 29, 2025, 10:30 ET Practice Management Systems Market is Projected to Reach US$36.33 billion at CAGR of 9.3% Amid Need for Operational Efficiency & Automation | The Insight Partners
national digitization projects that facilitate the transition of health professionals to automated digital platforms is the HITECH Act in the US, the NHS Long-Term Plan in the UK, and the Digital Health Mission in India. In many cases, the certified EHR and PMS systems are regulated by the authorities
More news about: The Insight Partners
Sep 23, 2025, 17:31 ET SGLT2 Inhibitors Market to Expand by 2034 as Companies Leverage Emerging Opportunities in Indications Such as Heart Failure, MASH, Obesity, PCOS, and Others | DelveInsight
with an SGLT2 inhibitor. In the United Kingdom, SGLT2 inhibitors are under review as potential first-line therapy in NHS guidelines, with dapagliflozin and empagliflozin already established in managing diabetes, heart failure, and CKD. The therapeutic scope of SGLT2
More news about: DelveInsight Business Research, LLP
Sep 23, 2025, 09:01 ET GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC
TalkDate/Time: Thursday, Oct. 23, 10:35-10:50 AM PT Title: NHS-Galleri trial: approaches to retain a diverse participant cohort across multiple trial appointments Presentation Type: Poster Title: Baseline
More news about: GRAIL, Inc.
Sep 23, 2025, 08:30 ET Ultromics Study Shows AI Could Improve Early Detection of Cardiac Amyloidosis
Ultromics is redefining cardiovascular care with FDA-cleared, AI-powered tools that enhance echocardiographic diagnosis. Built in partnership with the NHS and Mayo Clinic, its EchoGo® platform helps clinicians detect complex heart diseases earlier and more accurately—using nothing more than a
More news about: Ultromics
Sep 19, 2025, 10:01 ET Liver Cancer Therapeutics Market Size Surpasses USD 13.16 Billion by 2032, Increasing at a CAGR of 16.5% from 2025 to 2033
burden of liver disease linked to obesity, diabetes, and alcohol misuse is accelerating demand for effective HCC treatments. National Health Service (NHS) initiatives to expand early cancer diagnosis, along with faster access schemes for innovative oncology drugs, further drive uptake of immunotherapies
More news about: DataM Intelligence 4 Market Research LLP
Sep 17, 2025, 07:00 ET Insightec's Incisionless Focused Ultrasound Therapy Successfully Treats Downton Abbey Creator Lord Julian Fellowes for Essential Tremor
Imperial College Healthcare NHS Trust. "MR-guided focused ultrasound is a proven, safe, and effective incisionless option for patients who do not find relief with medication. By
More news about: Insightec
Sep 17, 2025, 07:00 ET BIMZELX® (bimekizumab-bkzx) Data in Moderate-to-Severe Plaque Psoriasis at EADV Showed Complete Skin Clearance Sustained Over Four Years
Richard B. Warren, Professor of Dermatology, University of Manchester and Northern Care Alliance NHS Foundation Trust. "It is therefore highly relevant to observe complete skin clearance sustained over four years in nearly half of patients who received
More news about: UCB
Sep 16, 2025, 09:00 ET Insightec's Incisionless Focused Ultrasound Therapy Successfully Treats Downton Abbey Creator Lord Julian Fellowes for Essential Tremor
Imperial College Healthcare NHS Trust. "MR-guided focused ultrasound is a proven, safe, and effective incisionless option for patients who do not find relief with medication. By
More news about: Insightec